Company: PTHS
Filing Date: 2025-08-28
Form Type: S-3
Source: 0001753926-25-001403
Chunk: 33

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-08-28
Form: S-3
Chunk 33
---
 pay
damages to our licensor, or we may be required to cease our development and commercialization activities that are deemed infringing,
and in such event

We may ultimately need to modify our
activities or technologies to design around such infringement, which may be time- and resource-consuming, and which ultimately
may not be successful. Any of the foregoing could have a material adverse effect on our business, financial condition, results
of operations and prospects.

In addition, our rights to certain
components of our technology platform, may be licensed to us on a non-exclusive basis. The owners of these non-exclusively licensed
technologies are therefore free to license them to third parties, including our competitors, on terms that may be superior to
those offered to us, which could place us at a competitive disadvantage.

Moreover, our licensors may own or
control intellectual property that has not been licensed to us and, as a result, we may be subject to claims, regardless of their
merit, that we are infringing or otherwise violating the licensor’s rights. In addition, certain of our agreements with
third parties may provide that intellectual property arising under these agreements, such as data that could be valuable to our
business, will be owned by the third party, in which case, we may not have adequate rights to use such data or have exclusivity
with respect to the use of such data, which could result in third parties, including our competitors, being able to use such data
to compete with us.

Third party intellectual property may prevent us from developing our potential products; our intellectual property may not prevent competition; and any intellectual property issues may be expensive and time consuming to resolve.

The manufacture, use or sale of our potential products may infringe the patent rights of others. If others obtain patents with conflicting claims, we may be required to obtain licenses to those patents or to develop or obtain alternative technology. We may not be able to obtain any such licenses on acceptable terms, or at all. Any failure to obtain such licenses could delay or prevent us from pursuing the development or commercialization of our potential products, platform and technology.

<div align='center'>17</div>

Generally, our success will depend on our and our licensors’ ability to obtain and maintain patents and other intellectual property rights for our potential products and technologies. our patent position is uncertain and involves complex legal and technical questions for which legal principles are unresolved. Even if we do obtain patents, such patents may not adequately protect the technology we own or have licensed